Research graph
References from Impact of primary tumor location on survival outcomes and recurrence patterns in patients with stage III non-small cell lung cancer: A retrospective observational study. Local targets link to admitted publications; unresolved targets remain external evidence.
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 · External reference
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship
10.1016/s0025-6196(11)60735-0 · 2008 · External reference
Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer
10.1200/jco.2009.26.2543 · 2010 · External reference
10.1016/j.jtho.2015.09.009
10.1016/j.jtho.2015.09.009 · 2016 · External reference
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical Practice Guidelines for diagnosis, treatment and follow-up
10.1093/annonc/mdx222 · 2017 · External reference
PACIFIC investigators, durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer
10.1056/nejmoa1709937 · 2017 · External reference
Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer
10.1200/jco.21.01308 · 2022 · External reference
Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
10.1093/ejcts/ezs065 · 2012 · External reference
Survival after resection for primary lung cancer: a population based study of 3211 resected patients
10.1136/thx.2005.056481 · 2006 · External reference
Lower lobe origin is a poor prognostic factor in locally advanced non-small-cell lung cancer patients treated with induction chemoradiotherapy
10.3892/mco.2015.509 · 2015 · External reference
Deciphering the clinical features of heterogeneous stage III non-small cell lung cancer in Japanese real-world clinical practice: expanded cohort of the SOLUTION study
10.1016/j.lungcan.2021.12.005 · 2022 · External reference
Effect of radiation therapy techniques on outcome in N3-positive IIIB non-small cell lung cancer treated with concurrent chemoradiotherapy
10.4143/crt.2014.131 · 2016 · External reference
Lower lobe origin is related to unfavorable outcomes in patients with stage I–III lung cancer treated with radical chemoradiotherapy
10.1177/0300891620971359 · 2021 · External reference
Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy
10.1016/s0360-3016(02)02803-1 · 2002 · External reference
Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
10.1016/s0360-3016(99)00183-2 · 1999 · External reference
Direct lymphatic drainage of lung segments to the mediastinal nodes. An anatomic study on 260 adults
10.1016/s0022-5223(19)34555-6 · 1989 · External reference
PACIFIC investigators, overall survival with durvalumab after chemoradiotherapy in Stage III NSCLC
10.1056/nejmoa1809697 · 2018 · External reference
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
10.1016/j.ejca.2008.10.026 · 2009 · External reference
The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
10.1016/s0140-6736(07)61602-x · 2007 · External reference
Poor prognosis of NSCLC located in lower lobe is partly mediated by lower frequency of EGFR mutations
2020 · External reference
Radiomics: extracting more information from medical images using advanced feature analysis
10.1016/j.ejca.2011.11.036 · 2012 · External reference
Prognostic value of metabolic tumor volume on [18F]FDG PET/CT in addition to the TNM classification system of locally advanced non-small cell lung cancer
10.1186/s40644-024-00811-7 · 2024 · External reference
Imaging heterogeneity in lung cancer: techniques, applications, and challenges
10.2214/ajr.15.15864 · 2016 · External reference
Radiomics in oncological PET/CT: a methodological overview
10.1007/s13139-019-00571-4 · 2019 · External reference
Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis
10.1016/j.athoracsur.2004.06.081 · 2005 · External reference
Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer
10.1016/j.ijrobp.2006.12.066 · 2007 · External reference
Novel biologic factors correlated to visceral pleural invasion in early-stage non-small cell lung cancer less than 3 cm
10.21037/jtd.2018.03.185 · 2018 · External reference
Pleural tags on CT scans to predict visceral pleural invasion of non-small cell lung cancer that does not abut the pleura
10.1148/radiol.2015151120 · 2016 · External reference
Lobectomy is the preferred choice rather than sublobar resection for centrally located clinical stage 1 non-small cell lung cancer
10.1093/ejcts/ezaf233 · 2025 · External reference
